Time to assess the effects of sodium-glucose co-transporter-2 inhibitors on the 'forgotten' right ventricle?

ESC Heart Fail. 2020 Feb;7(1):337-338. doi: 10.1002/ehf2.12550. Epub 2019 Dec 19.

Authors

Dimitrios Patoulias¹, Alexandra Katsimardou¹, Maria Toumpourleka¹, Christodoulos Papadopoulos², Michael Doumas^{1

3}

Affiliations

¹ Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital 'Hippokration', Thessaloniki, Greece.
² Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital 'Hippokration', Thessaloniki, Greece.
³ Veterans Affairs Medical Center, George Washington University, Washington, DC, USA.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Glucose
Heart Ventricles
Sodium
Sodium-Glucose Transporter 2 Inhibitors*
Symporters*
Ventricular Function, Left

Substances

Sodium-Glucose Transporter 2 Inhibitors
Symporters
Sodium
Glucose